Metastatic Cancer

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Immune Resistance Interrogation Study

Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer

Comparing Palliative Radiotherapy With or Without Carboplatin

Harvesting Cells for Experimental Cancer Treatments

Imaging of Solid Tumors Using FAP-2286

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer

IL-15 Enhanced NK Cell Therapy for Solid Tumors

Niraparib in Tumors Metastatic to the CNS

Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

FOG-001 in Locally Advanced or Metastatic Solid Tumors

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

Predicting Disease Progression and/or Recurrence in Cancer